Copyright © 2005, SAS Institute Inc. All rights reserved. Maintaining a Validated SAS Toolset Co-Presenters: Edward Helton and Patricia Halley.

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
Healthcare Link Initiatives: Bridging Clinical Research and Healthcare May 29, 2008 Bay Area Users’ Group Landen Bain CDISC Liaison to Healthcare.
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
Pertemuan 20 Matakuliah: A0214/Audit Sistem Informasi Tahun: 2007.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
An introduction to CDISC and CDASH Bring on the Standards! Emmanuelle Denis M.Sc., MICR Global Health Clinical Trials Research Programme.
Chapter 10 Information Systems Controls for System Reliability—Part 3: Processing Integrity and Availability Copyright © 2012 Pearson Education, Inc.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Good Laboratory Practices (GLPs)
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency1 GMP Workshop Kuala Lumpur.
Regulatory Overview.
ArtClinica Address: 1175 Marlkress Rd, #2632, Cherry Hill, NJ 08034, USAPhone: Fax: ARTClinica.
ENVIROTRAC: A Premier Chamber Monitoring and Data Acquisition System Envirotrac A Guided Tour.
Good Manufacturing Practices
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Contents Integrating clinical trial data Working with CROs
Investigational New Drug Application (IND)
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Principles of Information Systems, Sixth Edition Systems Design, Implementation, Maintenance, and Review Chapter 13.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
State Agencies’ Records Retention Schedule S6: Information Systems Records S6 Retention Schedules.
PwC 21 CFR Part 11 – A Risk Management Perspective Patrick D. Roche 07 March 2003, Washington D.C.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Principles of Information Systems, Sixth Edition Systems Design, Implementation, Maintenance, and Review Chapter 13.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Ali Pabrai, CISSP, CSCS ecfirst, chairman & ceo Preparing for a HIPAA Security Audit.
Part 11, Electronic Records; Electronic Signatures
QSR and GLP What exactly are these?.
School of Health Sciences Week 8! AHIMA Practice Briefs Healthcare Delivery & Information Management HI 125 Instructor: Alisa Hayes, MSA, RHIA, CCRC.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Principles of Information Systems, Sixth Edition 1 Systems Design, Implementation, Maintenance, and Review Chapter 13.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
1 Training the FDA on: eSystems Used in Clinical Trials SEC Associates, Inc.
All Hands Electronic Information Integrity Call White Paper An Introduction to the Current State of EMR – et.al. R. L. Chamberlain, Ph.D.
November 6, 2013 Purchasing Controls & Supplier Quality Best Practices Beyond Compliance for the Medical Device Industry AdvaMed 2013 Bernie Liebler Technology.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
FDA 21 CFR Part 11 Compliance
Good Clinical Practice (GCP) and Monitoring Practices
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
Basics of Building and Understanding Data Collection Forms
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Final HIPAA Security Rule
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
HIPAA SECURITY RULE Copyright © 2008, 2006, 2004 by Saunders an imprint of Elsevier Inc. All rights reserved.
How to build your Integrated
Managing Project Work, Scope, Schedules, and Cost
Introduction to the PACS Security
Regulatory Perspective of the Use of EHRs in RCTs
Understanding the Process of Documenting Informed Consent
Good clinical practice
Presentation transcript:

Copyright © 2005, SAS Institute Inc. All rights reserved. Maintaining a Validated SAS Toolset Co-Presenters: Edward Helton and Patricia Halley

Copyright © 2005, SAS Institute Inc. All rights reserved. 2 db  LIS HIS lab, ADT, meds, source documents  display eCRF complete chart note Merged workflow: clinical trial data captured in initial CDA, re-used in chart note validation Proposed processes (single source) CLINICCRO ODM CDA & CDISC in Starbrite Trial CDA(1) CDA(2) Source: Liora Alschuler, Landen Bain, Rebecca Kush, PhD.

Copyright © 2005, SAS Institute Inc. All rights reserved. 3 Near-term Goal: Create means of conversion to minimize risk of ODM adoption

Copyright © 2005, SAS Institute Inc. All rights reserved. 4 Agenda  Part 11 and the Predicate Rules  Applying the Predicate Rules to Maintenance of a Validated SAS Toolset  Support from SAS (now and future)

Copyright © 2005, SAS Institute Inc. All rights reserved. 5 Common Threads of GxPs  Calibrate  Test  Validate  Standardize  Retain Records  Maintain Written Procedures

Update on Part 11 GMP by the Sea August 25, 2004 Rick Friedman, Team Leader Guidance & Policy Division of Manufacturing and Product Quality Office of Compliance, CDER

Copyright © 2005, SAS Institute Inc. All rights reserved. 7 FDA Regulation References - GCP  Strong New FDA Industry Guidances in GCPs  – ( c) – sponsors shall review and evaluate evidence related to safety and effectiveness  (a) – Records must be Accurate & Complete  (a,b,c) – Investigator Recordkeeping - drug disposition, case histories, record retention

Copyright © 2005, SAS Institute Inc. All rights reserved. 8 FDA Regulation References - GMP  (a) – Quality control unit has the authority to approve and reject  ( c) – Records shall be kept of maintenance, cleaning, sanitizing, and inspection  – Validation requirements of automated equipment  (a) - Written procedures for production and process control  (a), (b), and ( c) – Retention period for records

Copyright © 2005, SAS Institute Inc. All rights reserved. 9 FDA Regulation References - GLP  (b) – must maintain current summary of training for those engaged, or supervising the conduct of a non-clinical study  (b) – all experimental data… must be accurately recorded  (b) (4) – periodically submit a written status report noting problems and corrections  ( c) – records maintained of all inspections, maintenance records, testing, calibration and/or standardizing operations

Copyright © 2005, SAS Institute Inc. All rights reserved. 10 FDA Regulation References - Devices  21 CFR (a) & (b) - Records must be Accurate & Complete  21 CFR – must retain records required by 812

Copyright © 2005, SAS Institute Inc. All rights reserved CFR Part 11- Upcoming Amendment  Comments collected on the existing rule  Support for Part 11 in general  It is not going away – expect rewrite in future

Copyright © 2005, SAS Institute Inc. All rights reserved. 13 Standard Data / JANUS  Tools to receive, upload and analyze data  Unambiguous path of the source data to the analysis findings (metadata, derivations, flags, imputations, source code, analysis files)  Focus on standard data and standard analysis makes maintaining validation even more critical – valid interface, interaction between SAS systems  This makes your SAS configuration even more important!

Copyright © 2005, SAS Institute Inc. All rights reserved. 14

Copyright © 2005, SAS Institute Inc. All rights reserved. 15

Copyright © 2005, SAS Institute Inc. All rights reserved. 16 Standard Data / JANUS  Right now it takes analysis of many applications to find common trends.  One study took 10 person years.  We don’t have that kind of time to “find” the right data.  Standardization enhances the need for a validated SAS system.

Copyright © 2005, SAS Institute Inc. All rights reserved. 17 SAS Validation of SAS9 Customer Validation of SAS9 -- Toolset Validated System AERS Interim Analysis Integrated Safety Report Customer Validation of SAS9 -- Applications

Copyright © 2005, SAS Institute Inc. All rights reserved. 18

Copyright © 2005, SAS Institute Inc. All rights reserved. 19 Configuration Management  Identify functional and physical characteristics  Manage changes to those characteristics Source -- IEEE

Copyright © 2005, SAS Institute Inc. All rights reserved. 20

Copyright © 2005, SAS Institute Inc. All rights reserved. 21 Managing Changes

Copyright © 2005, SAS Institute Inc. All rights reserved. 22 Identify and Describe Changes  Sources of Information Tech Support SAS Notes Mail & File Lists (TSNEWS-L) Monitoring Tools  Sources of SAS Updates Hot Fixes Service Packs

Copyright © 2005, SAS Institute Inc. All rights reserved. 23 Identify and Describe Changes - Future Electronic Software Downloads Automatic Alert Notification

Copyright © 2005, SAS Institute Inc. All rights reserved. 24 Request and Approve Changes  Classify Change  Submit Request  Obtain Approval

Copyright © 2005, SAS Institute Inc. All rights reserved. 25

Copyright © 2005, SAS Institute Inc. All rights reserved. 26 Implement and Verify Changes  Test environment  SASIQ/SASOQ  Data Migration

Copyright © 2005, SAS Institute Inc. All rights reserved. 27 Copyright © 2003, SAS Institute Inc. All rights reserved. SASIQ/SASOQ  Automated  Tested  Repeatable  Reports and Stores Results (XML) support.sas.com/rnd/migration/planning/validation /

Copyright © 2005, SAS Institute Inc. All rights reserved. 28

Copyright © 2005, SAS Institute Inc. All rights reserved. 29

Copyright © 2005, SAS Institute Inc. All rights reserved. 30 Data Migration  Proc Migrate  Migration Macros  Guidance and tools available at

Copyright © 2005, SAS Institute Inc. All rights reserved. 31 Implement and Verify Changes – Future  IQ/OQ Enhancements  Install Enhancements  Less media (1 instead of 19)

Copyright © 2005, SAS Institute Inc. All rights reserved. 32 Document  Initial Change Requests  IQ/OQ Output  SAS Logs  SAS Registry (Future)  Design / Configuration Specification Change Log

Copyright © 2005, SAS Institute Inc. All rights reserved. 33

Copyright © 2005, SAS Institute Inc. All rights reserved. 34 Security  Physical  Logical Operating System Level Account Maintenance Internet Security SAS Management Console

Copyright © 2005, SAS Institute Inc. All rights reserved. 35 Business Continuity  Backups  Redundancy  Environmental Controls  Disaster Recovery

End-to-End Seamless Integration; Semantic Interoperability Pharma Medical & Statistical Reviewers Approval Open Data Model - XML based, CDISC compliant Patients Subject CDMS Op DB Investigator Physician ODMSDTM LABADaM Source: Dave Iberson-Hurst

Copyright © 2005, SAS Institute Inc. All rights reserved. 37 Copyright © 2005, SAS Institute Inc. All rights reserved. 37